PF1022A
(1) is a twenty-four-membered anthelmintic cyclooctadepsipeptide that was isolated from the mycelial cake of Mycelia sterilia PF1022 by Sasaki et al. 1) Its analogues, PF1022B (2), C (3), D (4), E (5), F (6), G (7) and H (8) were also found in the same culture. [2] [3] [4] Before these compounds were isolated, bassianolide (9) 5) was the only natural product consisting of four L-N-methylamino acids and four D-2-hydroxy acids linked together in a pattern giving the molecule a two-fold axis of symmetry. Structurally analogous verticilide (FKI-1033, 10) has recently been reported as a ryanodine receptor antagonist.
6) The structures and biological activities of these compounds are summarized in Fig. 1 . These compounds have specific biological activity against their target organism without such other biological effects as antibacterial activity and cytotoxicity. PF1022A has been spotlighted in the animal health field because of its high anthelmintic efficacy against various parasites, even against benzimidazole-resistant and ivermectin-resistant Haemonchus contortus, 7) in addition to its low toxicity. 1) We therefore embarked of this study on depsipeptide chemistry to clarify the structure-activity relationship, with the objective of developing a new anthelmintic drug. Total syntheses of PF1022A and its related compounds were subsequently published within three years of its isolation (Nishiyama et al.; 8) Ohyama et al.; 9) Dutton and Nelson; 10) Kobayashi et al.; 11) and Scherkenbeck et al. 12) ). Although these synthetic methods are still highly valued, the conversion of such natural products is of practical use for them to be readily accessible. We report here the conversion of PF1022s and the structureactivity relationship of their analogues.
Results and Discussion
Conversion of PF1022A (1) PF1022A (1) was converted as summarized in Scheme 1. Catalytic oxidation of the benzene ring(s) of 1 by using ruthenium(III) chloride afforded versatile intermediates 11 and 12 possessing carboxyl group(s). Benzothiazole and benzimidazole derivatives 13 and 14 were respectively prepared in accordance with the method of Hendrickson and Hussoin 13) from 11 and 12. Compound 12 was amidated to give compounds 15, 16, 17, 18, 19 and 20 by the usual coupling reagents with amines. Nitration and successive hydrogenation of 1 yielded another key intermediate 22 8) which could be an alternative source of PF1022H (8) and was converted to the other benzothiazole derivatives 23, 24, and emodepside (25) 14) which is one of the active ingredients of Profender Ò launched in 2005 by Bayer HealthCare.
Conversion of PF1022E (5) and PF1022H (8)
Scheme 2 shows a summary of the method for converting PF1022E (5) . The nitrile group of compound 26 prepared from 5 was converted to tetrazole (27), imidazole (30), thiazole (31), and the primary amine (32) which was additionally modified to give the dialkylaminoethoxy derivatives (33-38). Methylation of 27 yielded two chromatographically separable isomers (28 and 29). The Mitsunobu reaction was applied to the phenolic hydroxyl group of 5 to afford the (S)-prolinol derivative (39) and furfuryl derivative (40). Derivatives 41-51 were prepared by typical O-alkylation of 5.
Compounds 52-60 were prepared from PF1022H (8) in almost the same manner as that used for the conversion of PF1022E. Scheme 3 summarizes the reactions.
y To whom correspondence should be addressed. Fax: +81-45-545-3120; E-mail: makoto.ohyama@meiji.com Abbreviations: Tf 2 O, trifluoromethanesulfonic anhydride; DEAD, diethyl azodicarboxylate; TFA, trifluoroacetic acid; DCC, 1,3-dicyclohexylcarbodiimide; HOBt, 1-hydroxybenzotriazole; PSA, polar surface area PF1022A (1) PF1022B (2) PF1022C (3) PF1022D (4) PF1022E (5) PF1022F (6) PF1022G (7) PF1022H (8) Bassianolide (9) Verticilide ( Insecticidal activity 16) and Weltz 17) have revealed the molecular target of PF1022A and emodepside to be G protein-coupled receptor depsiphilin[HC110-R], its structure remains unresolved, probably due to difficulty in crystallization. We therefore considered how the structural difference in the derivatives affected their efficacy in vivo. Table 1 summarizes the structures of the derivatives and their anthelmintic efficacy against Ascaridia galli, as well as their calculated physicochemical parameters. Calculated logarithm P(cLogP) is well known as one of the indices of lipophilicity, and the polar surface area (PSA) is used to explain intestinal absorption in combination with cLogP. 18, 19) These parameters should be taken into consideration for explaining the structureactivity relationship in vivo. Scherkenbeck et al. have recently reported in their studies on the conversion of PF1022A that a significant increase in lipophilicity of the derivatives resulted in a decrease of their bioavailability, and that all four leucines were necessary for high biological activity. 20) On the other hand, Jeschke et al. have pointed out that there were highly efficacious derivatives with more lipophilicity than PF1022A. The latter case for the increased activity of the derivatives was explained by the possible attribution of a more rigid bioactive conformation. 21, 22) However, these present studies were made with different species of parasites and infected animals in our experiments. The effect of lipophilicity may therefore vary according to such conditions.
The cLogP and PSA values for the derivatives were spotted on a chart to visualize the relationship between the anthelmintic efficacy and physicochemical parameters of the derivatives (Fig. 2) . The cLogP and PSA values for the highly efficacious compounds respectively ranged from 4.3 to 7.6 and from 100 to 194. These results indicate that both parameters had optimal ranges for the bioavailability of the compounds. Some derivatives showed, however, lower efficacy, although both physicochemical parameters were in the optimal ranges. (8) .
Ar is each benzene ring of the p-hydroxyphenyl-lactic acid moiety of PF1022H (8) . Reagents: a) K 2 CO 3 , NaI, BrCH 2 CN; b) H 2 (3 atm), Pd/C; c) H 2 , Pd/C, formaldehyde (for 53) or acetoaldehyde (for 54); d) K 2 CO 3 , NaI, 1,4-dibromobutane; e) (BrCH 2 CH 2 ) 2 O, NaI, K 2 CO 3 ; f) 2-chloromethylfuran, NaI, Cs 2 CO 3 ; g) 2-picolyl chloride, NaI, Cs 2 CO 3 ; h) K 2 CO 3 , benzylbromide (for 59) or isobutene, H 2 SO 4 (for 60). This may have been due to a structural and/or charge inadequacy in the binding affinity with the receptor as will be discussed later.
i) Mono-substitutional effect on a phenyllactate Carboxylic acid (12) and benzimidazole (14) both lost anthelmintic activity. It would appear that a drastic change to a benzene ring caused this adverse effect. Amide derivatives 15-20 were mainly designed to confirm the tolerance to a difference in the aromatic ring and its distance from the depsipeptide backbone.
Notwithstanding such difference, they had almost no efficacy, possibly because of biodegradation and/or mismatching with the putative receptor.
We next prepared diverse derivatives substituted at the para position of a benzene ring by an alkyl chain, a dialkylaminoethoxy group and a heterocycle, anticipating other possible effects such as hydrophobic interaction, electrostatic interaction and -stacking interaction.
O-alkyl derivatives 44-50 at the p-hydroxy group of 5 were comparable in efficacy to emodepside (25), whether having a branched or straight chain. However, 1) Score against Ascaridia galli in chicken at 5mg/kg dosage.
The score is expressed by +++ >90%, ++ 75-90%, + 50-75%, -<50% worm reduction.
longer alkyl chains tended to decrease the efficacy (see 51, Table 2 ). These results indicate that, at least in significant part, the side chain of the phenyllactate moiety was bound to a hydrophobic spatially extended pocket in the receptor. Derivatives possessing an aliphatic amine such as the dialkylaminoethoxy groups had almost no efficacy (33-39). A tertiary amine was thought to be unfavorable for receptor-binding, compound 35 being the only exception and an unknown reason.
The heteroarylmethyl derivatives (28-31, and 40-42) and the nitrile derivative (26) showed equivalent efficacy. These derivatives shared the common property of a hydrogen-bond-acceptor nitrogen or oxygen atom which was exposed, unlike the tertiary amine derivatives. Tetrazole is regarded as a carboxylic acid equivalent, and the PSA value for the derivative (27) was over-large for membrane permeability. Tetrazole (27) therefore lost its efficacy, despite the methyltetrazoles (28 and 29) retaining theirs. In respect of the pyridine derivatives, the 2-picolyl and 3-picolyl derivatives (41 and 42) had higher efficacy than the 4-picolyl derivative (43), probably because the position of the putative hydrogen bond donor of the receptor was rigidly regulated and the nitrogen atom of the 4-picolyl group was incompatible with it.
ii) Bis-substitutional effect on phenyllactates Carboxylic acid (11) and benzothiazoles (13, 23 and 24) prepared with the aim of altering the nature of the benzene ring lead to a negative effect. It is suggested that the benzene ring of PF1022A played an essential role in binding to the receptor or stabilizing the conformation via the intramolecular CH-interaction apparent in a crystalline structure.
23) The derivatives possessing nitro or amino groups (21 and 22) had no efficacy, probably due to low affinity with the receptor, based on the difference in electrostatic environment of the benzene rings.
An attempt to introduce such functional groups as furfuryl, 2-picolyl and t-butoxy to PF1022H (8) , which was effective for PF1022E (5), resulted in a worse effect than that expected (57, 58 and 60). One of those functional groups would presumably be required for receptor-binding, and its duplication made the molecule too large for bioavailability. The same would be true for the decreased anthelmintic efficacy of the derivative (59). In respect of derivatives 53-56, the most likely cause for the lost activity was a charge inadequacy for the binding affinity with the receptor, like the case of derivatives 33-39 as already described.
The compounds showing an anthelmintic score of +++ at a dosage of 5 mg/kg were next assayed at lower doses, with the results shown in Table 2 . Among these compounds, the methyltetrazole (28) and furfuryl derivative (40) showed higher efficacy than PF1022A (1) and emodepside (25).
The putative binding mode is illustrated in Fig. 3 based on the substantially clarified structure-activity relationship for the derivatives. The results obtained here are exemplified by the fact that altering the phenyllactate moiety significantly affected the anthelmintic efficacy. Unexplained parts of the structure may have had such effects as making the conformation more rigid, appropriately orienting the side chains, and maintaining the bioavailability as a whole molecule by controlling the physicochemical parameters represented by the cLogP and PSA values.
In summary, we provided versatile intermediates for further conversion of PF1022s, and identified more potent derivatives than both the parent compound and the launched product by considering the structureactivity relationship. Even though these highly efficacious compounds have not yet been fully investigated, continuing the search will lead us to find the best-inclass depsipeptide anthelmintic agents with the help of medicinal and computational chemistry, especially with a breakthrough in elucidating the complex structure of depsiphilin.
Experimental
The anthelmintic efficacy was measured as described as follows in the reference. 1) Each sample was orally administered to chickens infected with Ascaridia galli. The number of excreted worms was counted every day for the next two weeks. The chickens were sacrificed and the number of remaining worms was counted 2 weeks after the administration. The efficacy rate was calculated in accordance with the equation, efficacy rate[%] ¼ f(number of worms excreted)/ (total number of worms)g Â 100: The anthelmintic efficacy is classified into four levels depending on the efficacy rate:
cLogP values were calculated by LogP DB version 7.04 of ACD/ Labs, and PSA values were calculated by Sybyl-X version 1.2 of Tripos after optimizing the structure by Discovery Studio version 3.0 of Accerlys. Optical rotation data were recorded with a Jasco DIP-370 polarimeter, and 1 H-NMR data were recorded with a Jeol GSX-270 spectrometer or Jeol GSX-500 spectrometer. Chemical shift () data are referenced to tetramethylsilane (0.0 ppm) or the residual solvent peak as the internal standard (CDCl 3 , 7.26 ppm; CD 3 OD, 3.30 ppm). PF1022A and its derivatives were present as a mixture of two conformers in solution, 1) therefore, NMR data of the major conformer are listed unless otherwise noted. Some of the NMR data were recorded with potassium thiocyanate in order to make it easier to interpret them. 14 mmol) of orthoperiodic acid were dissolved in a mixture of CCl 4 (8 mL), CH 3 CN (8 mL) and water (12 mL). To this solution, 11.4 mg (approximately 0.043 mmol) of ruthenium (III) chloride n-hydrate was added at room temperature. A 9.1 g amount (39.9 mmol) of orthoperiodic acid was added twice at 2-h intervals, and the mixture was stirred overnight. The mixture was further stirred on an ice bath for 50 min after adding 5 mL of Et 2 O. The reaction mixture was diluted with water (30 mL) and extracted twice with CHCl 3 (30 mL, 30 mL). The organic layers were combined, dried over anhydrous sodium sulfate, and evaporated to dryness. The resulting residue was applied to silica gel column chromatography (CHCl 3 =MeOH ¼ 20=1 to 8/1) to give 2.85 g of a mixture of 11 and 12 with some impurities. This procedure was repeated to obtain a sufficient mixture of 11 and 12. To a solution of 14.25 g of this mixture of 11 and 12 in EtOAc(120 mL) was added dropwise a solution of 6.85 g (35.27 mmol) of diphenyl-diazomethane in EtOAc (50 mL). The mixture was then stirred overnight at room temperature. The reaction mixture was additionally stirred for 6 h after adding acetic acid (1.0 mL), and successively washed with saturated NaHCO 3 (100 mL), 10% KHSO 4 (100 mL), and brine (100 mL). The organic layer was dried over anhydrous sodium sulfate and evaporated to dryness. The resulting residue was applied to silica gel column chromatography (n-hexane/EtOAc ¼ 3=1 to 2/1) to give 4.07 g of the bisbenzhydryl ester of 11 and 6.21 g of the monobenzhydryl ester of 12. To a solution of 0.95 g (0.78 mmol) of this bisbenzhydryl ester in CH 2 Cl 2 (3 mL) was added TFA (3 mL), and the mixture was stirred for 3.5 h at room temperature. Concentration of the reaction mixture and purification by silica gel column chromatography (CHCl 3 =MeOH ¼ 100=3 to 10/1) gave 0.62 g (0.70 mmol) of pure 11 as a white amorphous powder. A mixture of 5.11 g (4.72 mmol) of the monobenzhydryl ester and 10%Pd/C (248 mg) in MeOH (100 mL) was stirred overnight in a hydrogen atmosphere. The mixture was filtered through Celite Ò , and the resulting filtrate was concentrated under reduced pressure. Purification by silica gel column chromatography (CHCl 3 =MeOH ¼ 50=1 to 10/1) gave 4.08 g (4.45 mmol) of pure 12 as a white amorphous powder.
11 (13) . To a solution of triphenylphosphine oxide (3.65 g, 13.12 mmol) in dichloroethane (20 mL) was added 9.5 mL of a 0.7 M solution of Tf 2 O in CH 2 Cl 2 in a nitrogen atmosphere at 0 C. After stirring for 30 min at the same temperature, a mixture of 11 (1.16 g, 1.31 mmol) and 2-aminobenzenethiol (0.31 mL, 2.90 mmol) in dichloroethane (11 mL) was added dropwise, before the mixture was heated to 80 C for 1 h. The reaction mixture was diluted with CHCl 3 (50 mL) and washed with water (30 mL). The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification by silica gel column chromatography (CHCl 3 =EtOAc ¼ 8=1 to 10/3) gave 0.26 g of 13 as a white amorphous powder (19%). ½ D 25 À65 (c 0.10, MeOH). (14) . The same procedure as that used for the preparation of 13 afforded 248 mg (13%) of 14 as a white amorphous powder from 1.68 g of 11 and 223 mg of 1,2-phenlenediamine. C. The mixture was stirred at 40 C for 2 h and then cooled to 0 C. To this solution was gradually added 15 mL of 28% NH 4 OH, the pH value being 9.5 at that point. The mixture was extracted twice with EtOAc (60 mL, 40 mL), and the organic layers were combined and successively washed with saturated NaHCO 3 (50 mL) and brine (50 mL). The organic layer was dried over anhydrous sodium sulfate and evaporated to dryness. The resulting residue was applied to silica gel column chromatography (CHCl 3 =MeOH ¼ 40=1 to 10/1) to give 748 mg of 23 as a white amorphous powder (66% C for 30 min. The resulting mixture was poured into water (40 mL) and then extracted three times with CHCl 3 (30 mL). The organic layers were combined, dried over anhydrous sodium sulfate and evaporated to dryness. The resulting residue was applied to silica gel column chromatography (CHCl 3 =EtOAc ¼ 1=1 to CHCl 3 =MeOH ¼ 30=1) to give 289 mg of 24 as a white amorphous powder (56%). ½ D 25 À74 (c 0.11, MeOH). Compounds 26, 41-49 and 51 were prepared according to the same typical procedure (Method A or Method B).
Method A. A mixture of 5 (1.0 mmol), alkyl halide (2-10 mmol), K 2 CO 3 or Cs 2 CO 3 (2-5 mmol) and NaI (0.1-1 mmol, if needed) in acetone (20-30 mL) was stirred at room temperature for 3-24 h. The reaction mixture was diluted with EtOAc (100 mL), and the organic layer was successively washed with saturated NaHCO 3 (70 mL), 10% KHSO 4 (70 mL), and brine (70 mL). The organic layer was dried over anhydrous sodium sulfate and evaporated to dryness. The resulting residue was applied to silica gel column chromatography to give the desired compound.
Method B. A mixture of 5 (1.0 mmol), alkyl halide (3-10 mmol) and NaH (1.9-2.4 mmol) in THF (20 mL) was stirred for 3-24 h at room temperature in a nitrogen atmosphere. The reaction mixture was poured into EtOAc (100 mL) and brine (60 mL) in separating funnel. The organic layer was separated, dried over anhydrous sodium sulfate and evaporated to dryness. The resulting residue was applied to silica gel column chromatography to give the desired compound. The physicochemical data are presented in Supplemental Materials. C for 14 h. The reaction mixture was diluted with EtOAc (50 mL), and successively washed with 4% NaHCO 3 (30 mL), 10% KHSO 4 (30 mL) and brine (30 mL). The organic layer was dried over anhydrous sodium sulfate and evaporated. The resulting residue was applied to silica gel column chromatography (CHCl 3 =MeOH ¼ 20=1 containing 0.05% acetic acid) to give 518 mg of 27 as a white amorphous powder (99%). (3H, s), 3.01 (3H, s), 3.02 (3H, s), 3.02-3.23 (4H, m), 4.38 (3H, s) 0 -diethyl dithiophosphate were dissolved in a mixture of CHCl 3 (2 mL), toluene (2 mL) and water (0.35 mL), and the solution was stirred at 80 C for 30 min. The reaction mixture was diluted with EtOAc (100 mL), and successively washed with water (50 mL) and saturated NaHCO 3 (50 mL). The organic layer was dried over anhydrous sodium sulfate and evaporated. The resulting residue was applied to silica gel column chromatography (CHCl 3 =EtOAc ¼ 5=1 to 1/1) to give 1.67 g of the thioamide intermediate as a white amorphous powder (78%). To a solution of this thioamide (403 mg, 0.388 mmol) in acetone (40 mL) was added MeI (0.25 mL, 4.02 mmol), and the mixture was stirred for 2 d at 30
C. The reaction mixture was concentrated and dissolved in benzene (4 mL). To this solution was added aminoacetaldehyde dimethylacetal (0.04 mL, 0.37 mmol), and the mixture was refluxed for 90 min. A 4 mL amount of 6N HCl was added to this solution, and the mixture was stirred at 100
C for 1 h. The reaction mixture was diluted with EtOAc (50 mL), and successively washed with a mixture of 2N NaOH (10 mL) and saturated NaHCO 3 (30 mL), and brine (30 mL). The organic layer was dried over anhydrous sodium sulfate and evaporated. The resulting residue was applied to silica gel column chromatography (CHCl 3 =MeOH ¼ 100=1 to 30/1) to give 231 mg of 30 as a white amorphous powder (57%).
To a solution of 280 mg (0.270 mmol) of this thioamide just obtained in toluene (1.5 mL) was added 0.5 mL (3.3 mmol) of bromoacetaldehyde diethylacetal and conc. H 2 SO 4 (2 drops). The reaction mixture was stirred at 90 C for 30 min and then diluted with EtOAc (30 mL). The organic layer was washed with saturated NaHCO 3 (20 mL), dried over anhydrous sodium sulfate and evaporated. The resulting residue was applied to silica gel column chromatography (CHCl 3 =EtOAc ¼ 4=1 to 2/1) to give 87 mg of 31 as a white amorphous powder (30% , 10%Pd/C (50 mg) and conc. HCl (0.2 mL) in EtOH (15 mL) was stirred at room temperature in a hydrogen atmosphere at 3 atm for 16 h. The reaction mixture was filtered, and the resulting filtrate was concentrated under reduced pressure. The resulting residue was dissolved in dioxane (10 mL) and water (10 mL). To this solution were added 0.25 mL (1.80 mmol) of triethylamine and 240 mg (1.10 mmol) of di-tert-butyl dicarbonate. The mixture was stirred at room temperature for 2.5 h and then concentrated under reduced pressure to remove the dioxane. To the resulting residue were added EtOAc (50 mL) and 5% citric acid (30 mL). The organic layer was dried over anhydrous sodium sulfate and evaporated. The resulting residue was applied to silica gel column chromatography (CHCl 3 =EtOAc ¼ 2=1) to give 296 mg of the Boc derivative of 32 as a white amorphous powder (58%). Compound 32 was quantitatively yielded by being treated with TFA and then neutralized for use without further purification. (3S,6R,9S,12R,15S,18R,21S,24R)-6-benzyl-18-(4-(2-(dimethylamino)ethoxy)benzyl)-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosan-2,5,8,11,14 (3S,6R,9S,12R,15S,18R,21S,24R)-6-benzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-18-(4-((S)-pyrrolidin-2-ylmethoxy) benzyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosan-2,5, 8,11,14,17, 20,23-octaone (39) . To a solution of 522 mg (2.594 mmol) of (S)-tertbutyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate in THF (5 mL) were added DEAD (0.16 mL, 1.02 mmol) and PPh 3 (271 mg, 1.03 mmol). After 30 min of stirring, 500 mg (0.518 mmol) of PF1022E (5) was added, and the mixture was stirred overnight. DEAD (0.16 mL, 1.02 mmol) and PPh 3 (271 mg, 1.03 mmol) were added again, and the reaction mixture was stirred at room temperature for 10 d. After concentration, the resulting residue was diluted with EtOAc (50 mL) and washed with water (50 mL). The organic layer was dried over anhydrous magnesium sulfate and evaporated. The resulting residue was applied to silica gel column chromatography (CHCl 3 =MeOH ¼ 20=1) to give 386 mg of the Boc derivative of 39 as a white amorphous powder (65%). A 182 mg amount of 39 was obtained as a white amorphous powder (51%) by treating with TFA, subsequent neutralization and silica gel column chromatography (CHCl 3 =MeOH ¼ 20=1 to 10/1). ½ D 25 À80 (c 0.11, MeOH). To a solution of 701 mg (0.726 mmol) of 5 in CH 2 Cl 2 (10 mL) were added 1.4 mL of isobutene and 0.11 mL of H 2 SO 4 at À40 C. After stirring for 2 h at room temperature, 0.6 mL of triethylamine was added at 0 C. The reaction mixture was concentrated under reduced pressure. The resulting residue was dissolved in 70 mL of EtOAc and successively washed with 5% KHSO 4 (70 mL) and brine (70 mL). The organic layer was dried over anhydrous magnesium sulfate and evaporated. The resulting residue was applied to silica gel column chromatography (CHCl 3 =EtOAc ¼ 4=1) to give 578 mg of 50 as a white amorphous powder (78% 
